Policy & Strategy
National biomanufacturing strategies and public investment — GFI, India's BioE3, the US Bioeconomy initiative, the EU Biotech Act and more.
Latest Policy & Strategy news
Scientists Are Using Darwinian Evolution & AI to Create Next-Gen Sustainable Proteins
Read at Green Queen Media →Vivici, dsm-firmenich and DAB.bio Test Cell Clumping as a Route to Continuous Precision Fermentation
Read at Cultivated X →WHO Partners with GFI APAC to Publish Public Health Report on Alternative Proteins
Read at Green Queen Media →What Will Decide Saudi Arabia’s Next Biotechnology Decade?
Read at The Scientist →How extreme weather and global conflicts are testing Chinese food security
Read at South China Morning Post →How Singapore is transforming its energy and chemicals sector
Read at Singapore Economic Development Board (EDB) →From the knowledge base
ASHG: Long-Read Genomics Meets Clinical Data in PacBio, Verily Health AI Deal
A multi-year collaboration will connect PacBio's HiFi sequencing with Verily Pre, combining long-read genomic and clinical data for biomedical research and AI model development.
5 iced coffees we're bringing to a job interview
A viral post sparked debate around the professionalism of iced coffee. Explore the gallery for our five natural iced coffee picks sure to impress.
It will take more than data to improve traceability in the cotton supply chain
New research supported by Cotton Diaries explores the idea of "relational traceability" and making farmers a key source of intel.
Former MIT professor David Sabatini awarded $6M in defamation case
A Massachusetts jury awarded $6 million in damages to prominent biologist David Sabatini, years after sexual harassment allegations led to his ouster from MIT. Roughly five years ago, Sabatini brought the
How this plastic-free personal care brand tackles men's reproductive health
Learn about Old Salt Grooming's plastic-free product line paired with broader messaging around men's reproductive health and the environmental cost of personal care.
Antheia gets $80M conditional DOD loan to onshore to the US
Biosynthesis manufacturer Antheia has won a conditional loan of $80 million from the US Department of Defense to help boost the domestic production of generic drugs. "Over time, we aim to manufacture Antheia's full pipeline ...